| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Lumbar hyperlordosis | 6.45e-06 | 99 | 15 | 5 | HP:0002938 | |
| HumanPheno | Hyperlordosis | 2.30e-05 | 222 | 15 | 6 | HP:0003307 | |
| HumanPheno | Lordosis | 2.30e-05 | 222 | 15 | 6 | HP:0002939 | |
| HumanPheno | Respiratory failure | 5.91e-05 | 262 | 15 | 6 | HP:0002878 | |
| MousePheno | abnormal pharyngeal arch artery morphology | 7.63e-08 | 47 | 33 | 5 | MP:0002672 | |
| MousePheno | abnormal fourth pharyngeal arch morphology | 2.21e-07 | 23 | 33 | 4 | MP:0006340 | |
| MousePheno | abnormal pharyngeal arch morphology | 2.58e-06 | 171 | 33 | 6 | MP:0002884 | |
| MousePheno | abnormal fourth pharyngeal arch artery morphology | 7.97e-06 | 17 | 33 | 3 | MP:0006354 | |
| MousePheno | abnormal aortic arch morphology | 8.06e-06 | 119 | 33 | 5 | MP:0004113 | |
| MousePheno | right aortic arch | 1.14e-05 | 60 | 33 | 4 | MP:0004158 | |
| MousePheno | abnormal aorta morphology | 1.25e-05 | 225 | 33 | 6 | MP:0000272 | |
| MousePheno | abnormal artery development | 1.39e-05 | 133 | 33 | 5 | MP:0003410 | |
| MousePheno | abnormal thoracic aorta morphology | 1.44e-05 | 134 | 33 | 5 | MP:0010468 | |
| MousePheno | abnormal craniofacial development | 4.92e-05 | 425 | 33 | 7 | MP:0003935 | |
| MousePheno | abnormal artery morphology | 6.13e-05 | 440 | 33 | 7 | MP:0002191 | |
| MousePheno | abnormal systemic artery morphology | 6.80e-05 | 304 | 33 | 6 | MP:0011655 | |
| MousePheno | interrupted aortic arch | 1.20e-04 | 41 | 33 | 3 | MP:0004157 | |
| MousePheno | interrupted aorta | 1.39e-04 | 43 | 33 | 3 | MP:0010544 | |
| MousePheno | abnormal heart atrium morphology | 1.96e-04 | 232 | 33 | 5 | MP:0003105 | |
| MousePheno | abnormal heart septum morphology | 2.58e-04 | 388 | 33 | 6 | MP:0006113 | |
| MousePheno | ventricular septal defect | 3.38e-04 | 261 | 33 | 5 | MP:0010402 | |
| MousePheno | abnormal cell adhesion | 5.65e-04 | 69 | 33 | 3 | MP:0003566 | |
| MousePheno | interrupted aortic arch, type b | 6.35e-04 | 16 | 33 | 2 | MP:0011659 | |
| Domain | BAT2_N | 1.55e-05 | 3 | 43 | 2 | PF07001 | |
| Domain | BAT2_N | 1.55e-05 | 3 | 43 | 2 | IPR009738 | |
| Domain | PRRC2 | 1.55e-05 | 3 | 43 | 2 | IPR033184 | |
| Domain | Calx_beta | 1.44e-04 | 8 | 43 | 2 | SM00237 | |
| Domain | Calx_beta | 1.84e-04 | 9 | 43 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.84e-04 | 9 | 43 | 2 | PF03160 | |
| Domain | PHD | 6.84e-04 | 75 | 43 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 7.96e-04 | 79 | 43 | 3 | IPR019787 | |
| Domain | PHD | 1.12e-03 | 89 | 43 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.20e-03 | 91 | 43 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.36e-03 | 95 | 43 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.40e-03 | 96 | 43 | 3 | PS01359 | |
| Domain | BROMODOMAIN_1 | 3.28e-03 | 37 | 43 | 2 | PS00633 | |
| Domain | Bromodomain | 3.45e-03 | 38 | 43 | 2 | PF00439 | |
| Domain | RGS | 3.63e-03 | 39 | 43 | 2 | IPR016137 | |
| Domain | BROMODOMAIN_2 | 4.01e-03 | 41 | 43 | 2 | PS50014 | |
| Domain | BROMO | 4.20e-03 | 42 | 43 | 2 | SM00297 | |
| Domain | Bromodomain | 4.20e-03 | 42 | 43 | 2 | IPR001487 | |
| Domain | - | 4.20e-03 | 42 | 43 | 2 | 1.20.920.10 | |
| Domain | Znf_FYVE_PHD | 4.68e-03 | 147 | 43 | 3 | IPR011011 | |
| Domain | WW | 5.24e-03 | 47 | 43 | 2 | PF00397 | |
| Domain | WW | 5.46e-03 | 48 | 43 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 6.15e-03 | 51 | 43 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 6.15e-03 | 51 | 43 | 2 | PS01159 | |
| Domain | WW_dom | 6.38e-03 | 52 | 43 | 2 | IPR001202 | |
| Domain | Zinc_finger_PHD-type_CS | 9.82e-03 | 65 | 43 | 2 | IPR019786 | |
| Domain | CH | 9.82e-03 | 65 | 43 | 2 | SM00033 | |
| Domain | CH | 1.13e-02 | 70 | 43 | 2 | PF00307 | |
| Domain | - | 1.16e-02 | 71 | 43 | 2 | 1.10.418.10 | |
| Domain | CH | 1.23e-02 | 73 | 43 | 2 | PS50021 | |
| Pubmed | Expression of Fraser syndrome genes in normal and polycystic murine kidneys. | 4.69e-06 | 3 | 44 | 2 | 21993971 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 8.28e-06 | 31 | 44 | 3 | 25838543 | |
| Pubmed | 9.00e-06 | 1116 | 44 | 9 | 31753913 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 24101214 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 18563433 | ||
| Pubmed | Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development. | 1.56e-05 | 5 | 44 | 2 | 17251066 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 23764775 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 17596926 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.97e-05 | 934 | 44 | 8 | 33916271 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 17462874 | ||
| Pubmed | 6.15e-05 | 332 | 44 | 5 | 37433992 | ||
| Pubmed | 6.39e-05 | 549 | 44 | 6 | 38280479 | ||
| Pubmed | 6.74e-05 | 1442 | 44 | 9 | 35575683 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 6.99e-05 | 10 | 44 | 2 | 15345741 | |
| Pubmed | The mouse adducin gene family: alternative splicing and chromosomal localization. | 8.54e-05 | 11 | 44 | 2 | 10602987 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 9.13e-05 | 361 | 44 | 5 | 26167880 | |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 1.02e-04 | 12 | 44 | 2 | 12906860 | |
| Pubmed | The identification of novel sequences expressed in the mouse notochord. | 1.02e-04 | 12 | 44 | 2 | 9021147 | |
| Pubmed | 1.45e-04 | 210 | 44 | 4 | 16565220 | ||
| Pubmed | 1.60e-04 | 407 | 44 | 5 | 12693553 | ||
| Pubmed | 1.86e-04 | 16 | 44 | 2 | 15878328 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 1.93e-04 | 424 | 44 | 5 | 21731673 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.09e-04 | 231 | 44 | 4 | 16452087 | |
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 2.10e-04 | 17 | 44 | 2 | 10716735 | |
| Pubmed | MOZ directs the distal-less homeobox gene expression program during craniofacial development. | 2.10e-04 | 17 | 44 | 2 | 31340933 | |
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 24740910 | ||
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 14730302 | ||
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 27984743 | ||
| Pubmed | 2.41e-04 | 95 | 44 | 3 | 20843830 | ||
| Pubmed | 2.64e-04 | 19 | 44 | 2 | 15024025 | ||
| Pubmed | 2.66e-04 | 246 | 44 | 4 | 15345747 | ||
| Pubmed | 2.93e-04 | 20 | 44 | 2 | 18162579 | ||
| Pubmed | 3.56e-04 | 22 | 44 | 2 | 22305495 | ||
| Pubmed | 3.56e-04 | 22 | 44 | 2 | 38507412 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.69e-04 | 759 | 44 | 6 | 35915203 | |
| Pubmed | 3.89e-04 | 23 | 44 | 2 | 17203973 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.14e-04 | 123 | 44 | 3 | 26912792 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 6.90e-04 | 317 | 44 | 4 | 17620599 | |
| Pubmed | 7.31e-04 | 322 | 44 | 4 | 26514267 | ||
| Pubmed | 8.75e-04 | 591 | 44 | 5 | 15231748 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 8.80e-04 | 148 | 44 | 3 | 32538781 | |
| Pubmed | 9.33e-04 | 151 | 44 | 3 | 17043677 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.01e-03 | 351 | 44 | 4 | 38297188 | |
| Pubmed | 1.04e-03 | 157 | 44 | 3 | 30186101 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 1.11e-03 | 624 | 44 | 5 | 33729478 | |
| Pubmed | 1.13e-03 | 39 | 44 | 2 | 24709693 | ||
| Cytoband | 15q22 | 3.59e-04 | 29 | 44 | 2 | 15q22 | |
| Cytoband | 9q31.1 | 7.19e-04 | 41 | 44 | 2 | 9q31.1 | |
| Cytoband | 1q23.3 | 1.03e-03 | 49 | 44 | 2 | 1q23.3 | |
| Cytoband | 17q21.31 | 2.84e-03 | 82 | 44 | 2 | 17q21.31 | |
| GeneFamily | PHD finger proteins | 4.39e-04 | 90 | 30 | 3 | 88 | |
| GeneFamily | Olfactory receptors, family 13 | 6.59e-04 | 23 | 30 | 2 | 162 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.42e-05 | 189 | 43 | 5 | M3112 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 2.37e-05 | 102 | 43 | 4 | M2124 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 1.11e-05 | 157 | 40 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.85e-08 | 186 | 44 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.44e-08 | 192 | 44 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 44 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 44 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 44 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 9.59e-06 | 135 | 44 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 168 | 44 | 4 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.43e-05 | 171 | 44 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-05 | 183 | 44 | 4 | 159d9ca6a2b4512f28064d9227c83e343503ac14 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-05 | 183 | 44 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 184 | 44 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 184 | 44 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-05 | 190 | 44 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.82e-05 | 192 | 44 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.82e-05 | 192 | 44 | 4 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.90e-05 | 193 | 44 | 4 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 194 | 44 | 4 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 195 | 44 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 195 | 44 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.14e-05 | 196 | 44 | 4 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.39e-05 | 199 | 44 | 4 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.48e-05 | 200 | 44 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Intermediate|1m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-05 | 200 | 44 | 4 | 805f50236113713b02f77aa5e208efb3b3b959d5 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_Synovial_Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.95e-04 | 114 | 44 | 3 | 674d34a35f403ba938a2a109a68bf34bdc3657c9 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_Synovial_Sarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.95e-04 | 114 | 44 | 3 | cbed6161fc307056ef1ac08b0f62c8c544866884 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 2.05e-04 | 116 | 44 | 3 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.38e-04 | 122 | 44 | 3 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.74e-04 | 128 | 44 | 3 | 3ca9ae69fb8cb7f8acb7540aa71778bc917da4df | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 145 | 44 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.27e-04 | 149 | 44 | 3 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 150 | 44 | 3 | 580ed7733857402345f43ca2623f72cdd1edf22c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-04 | 156 | 44 | 3 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 4.88e-04 | 156 | 44 | 3 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.97e-04 | 157 | 44 | 3 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 4.97e-04 | 157 | 44 | 3 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-04 | 157 | 44 | 3 | a633fb8e7a009490c6002bf272eceaf317f27af6 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 5.06e-04 | 158 | 44 | 3 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.16e-04 | 159 | 44 | 3 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.25e-04 | 160 | 44 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 5.35e-04 | 161 | 44 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.45e-04 | 162 | 44 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.45e-04 | 162 | 44 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 165 | 44 | 3 | 28e3083ab90eb02141f844b7f8a218ec9c43dbf9 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 165 | 44 | 3 | 54706631d819f401988e2c733dd6e59401a3585d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-04 | 165 | 44 | 3 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.95e-04 | 167 | 44 | 3 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.95e-04 | 167 | 44 | 3 | 18e336faa2d2429ab49d1c6ae9bbf9923d74aa8d | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 6.48e-04 | 172 | 44 | 3 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.59e-04 | 173 | 44 | 3 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-04 | 173 | 44 | 3 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.70e-04 | 174 | 44 | 3 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.81e-04 | 175 | 44 | 3 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.93e-04 | 176 | 44 | 3 | 3bf8ef0afad8c96f814355ead5b993d58cd1ce35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.04e-04 | 177 | 44 | 3 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 7.04e-04 | 177 | 44 | 3 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.04e-04 | 177 | 44 | 3 | db6de487ef7976b444afadbf3ac60b3259925566 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 178 | 44 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.16e-04 | 178 | 44 | 3 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-04 | 178 | 44 | 3 | 61363c3365d3e191c47be1b2a35fa8afbfa64ff2 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 178 | 44 | 3 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.16e-04 | 178 | 44 | 3 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-04 | 178 | 44 | 3 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-04 | 179 | 44 | 3 | 1309d41dbf286e9230fde6a7949e60c24d86766a | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.39e-04 | 180 | 44 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 7.51e-04 | 181 | 44 | 3 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.51e-04 | 181 | 44 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.51e-04 | 181 | 44 | 3 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-04 | 182 | 44 | 3 | 6339fc979aa097627924849f436bb9e9c14f4ce3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-04 | 183 | 44 | 3 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.75e-04 | 183 | 44 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.75e-04 | 183 | 44 | 3 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Healthy-CD8+_T_naive|Healthy / disease group, cell group and cell class | 7.75e-04 | 183 | 44 | 3 | 5e7a611cfb8a21106bb07361878ccc77ff251502 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-04 | 183 | 44 | 3 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.75e-04 | 183 | 44 | 3 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 7.88e-04 | 184 | 44 | 3 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.88e-04 | 184 | 44 | 3 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 7.88e-04 | 184 | 44 | 3 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 184 | 44 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.00e-04 | 185 | 44 | 3 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.00e-04 | 185 | 44 | 3 | 4a5e70ac41e5f3b25a773304ffef3c2a3dd5549d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.00e-04 | 185 | 44 | 3 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.00e-04 | 185 | 44 | 3 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.00e-04 | 185 | 44 | 3 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.00e-04 | 185 | 44 | 3 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.13e-04 | 186 | 44 | 3 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-04 | 186 | 44 | 3 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue | 8.13e-04 | 186 | 44 | 3 | 5108d9b7a081876ca34594b110d58df56063f542 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-04 | 187 | 44 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-04 | 187 | 44 | 3 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.25e-04 | 187 | 44 | 3 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-04 | 187 | 44 | 3 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.38e-04 | 188 | 44 | 3 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.38e-04 | 188 | 44 | 3 | 467773d1e6b4828495a62f3b92996964d1c94b97 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | 2c4432cada1273d08cbdc2824922cf578e448ec8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.38e-04 | 188 | 44 | 3 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.38e-04 | 188 | 44 | 3 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| Disease | testosterone measurement | 3.78e-04 | 1275 | 42 | 8 | EFO_0004908 | |
| Disease | pancreatic cancer (is_marker_for) | 4.06e-04 | 101 | 42 | 3 | DOID:1793 (is_marker_for) | |
| Disease | gamma-glutamyltyrosine measurement | 6.79e-04 | 27 | 42 | 2 | EFO_0021144 | |
| Disease | Parkinson disease | 1.11e-03 | 321 | 42 | 4 | MONDO_0005180 | |
| Disease | urate measurement | 1.58e-03 | 895 | 42 | 6 | EFO_0004531 | |
| Disease | cognitive inhibition measurement | 2.32e-03 | 50 | 42 | 2 | EFO_0007969 | |
| Disease | cognitive behavioural therapy | 3.11e-03 | 58 | 42 | 2 | EFO_0007820 | |
| Disease | waist circumference | 3.19e-03 | 429 | 42 | 4 | EFO_0004342 | |
| Disease | neuroimaging measurement | 3.83e-03 | 1069 | 42 | 6 | EFO_0004346 | |
| Disease | Petit mal status | 4.12e-03 | 67 | 42 | 2 | C0270823 | |
| Disease | Grand Mal Status Epilepticus | 4.12e-03 | 67 | 42 | 2 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 4.12e-03 | 67 | 42 | 2 | C0751522 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MREAMAEMPFMHSLS | 1356 | Q9NR48 | |
| MPAMRMDRGVSMPNM | 696 | O14639 | |
| SPEEHLEEMMKMMSP | 361 | Q9UIG0 | |
| TVREETMMVMTEDMP | 1976 | P11532 | |
| MDHMIMTPEMPTMEP | 1356 | Q9NZN5 | |
| MEDSMDMDMSPLRPQ | 1 | P06748 | |
| MMMVLRNLSMEPTFA | 1 | Q8NGL3 | |
| ASMQMASTIPTEMMI | 10511 | Q8WXI7 | |
| EMMMMSSSPSKPSSE | 71 | O60721 | |
| MMLIPMASVMAVTEP | 1 | Q9BVA6 | |
| TAPKPSFVAMMMMEV | 316 | Q5SZK8 | |
| PEMFMREFMVMEGMS | 1191 | Q5SZK8 | |
| MAPCMRAFLERLPMM | 3846 | Q15751 | |
| LMRTMGYMPTEMELI | 56 | Q9NP86 | |
| MMPVNSEVMYPHLME | 66 | Q9BZD4 | |
| MADTFTEIMTMMSPS | 511 | Q9ULH7 | |
| FPLSMLPMMISSMLQ | 591 | Q92887 | |
| SMFYGVMTPMMNPLI | 281 | Q8NGS9 | |
| APSMQNMETSPMMDV | 1521 | Q92794 | |
| MSAAFPPSLMMMQRP | 1 | P52951 | |
| IFPTMMVCMMAWRPI | 96 | Q5J8M3 | |
| MMCEVMPTINEDTPM | 1 | O75334 | |
| SMFYGVMTPMMNPLI | 281 | Q8NGT0 | |
| ENTPPRPSFMATMMM | 301 | P0C091 | |
| RPSFMATMMMEVDPL | 306 | P0C091 | |
| MSMLQMRAPVSEAMS | 536 | Q8NET4 | |
| MRAPVSEAMSMPQMR | 541 | Q8NET4 | |
| VRMTSANMDPAMMFR | 1051 | Q8TEU7 | |
| DPILMFFIMAAMLSM | 196 | Q9UKY4 | |
| SSPMPQMGSERMEMR | 166 | O76081 | |
| QMNPPEFEMIEDMAM | 96 | Q9Y2K3 | |
| RGMRPKMMMPFDSQP | 1231 | Q92859 | |
| RPEVEETSMPMTMVF | 856 | Q6ZUM4 | |
| QSYMDPRMMSGRPAM | 741 | Q9Y520 | |
| QMAMMEPGTEAMEPV | 336 | O15446 | |
| ASEELMPLMPMAMLI | 621 | Q8IUH8 | |
| MMEMNSHRASPPMTV | 3641 | P08F94 | |
| MDMNSFSPMMPTSPL | 1 | Q9UNH6 | |
| ISDPMLSFMMPFDLM | 66 | Q6ICG8 | |
| DPRWMMMPSYMDPRI | 671 | Q5JSZ5 | |
| VEDMMVMGRKPDPMC | 431 | Q2TAL5 | |
| MPTQLEMAMDTMIRI | 1 | Q8WXG8 | |
| MASPEMMIQIMENPF | 176 | Q9UHD9 | |
| SMMSYERSMMSPMAE | 1016 | P18583 | |
| MMSAYERSMMSPMAD | 1066 | P18583 | |
| SPMADRSMMSMGADR | 1076 | P18583 | |
| PSYPTMAMPSLLMMV | 226 | Q8IZ20 | |
| KTMSPSQMIMPNVME | 846 | Q9ULJ6 | |
| IMTVTTPEMVMPSSM | 1286 | Q15911 | |
| PMELPIFSPLMMQTM | 2091 | Q15911 |